Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2451-2025

Akreos, SKU: AO60P0300. Akreos intraocular lenses Recall

Akreos, SKU: AO60P0300. Akreos intraocular lenses

FDA recall Class III

Ongoing

FDA lists this Class III recall for Akreos, SKU: AO60P0300. Akreos intraocular lenses. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2451-2025
Recall classification
Class III
Enforcement status
Ongoing
Initiation date
Jun 6, 2025
FDA report date
Sep 3, 2025
Quantity in commerce
2
Distribution
See key details
FDA cause
Process control

What is being recalled?

Akreos, SKU: AO60P0300. Akreos intraocular lenses

Affected model & UDI checker

Search the exact identifiers published for Z-2451-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedAkreos, SKU: AO60P0300. Akreos intraocular lensesCheck source notice10757770501783
FDA code information

UDI-DI: 10757770501783, Lot: 1Q29212, Serial Numbers: 1Q29212006 and 1Q29212010

View the original FDA recall notice

Why was this product recalled?

An off-power error was identified, which resulted in a diopter of 16, rather than the intended 3 diopter. Implantation of affected intraocular lens could result in functional visual impairment or reduction in visual acuity which could result in the need for optical or surgical correction.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Bausch & Lomb Surgical, Inc. take?

6/6/2025, recall notices were emailed to customers who were asked to do the following: 1) Check your inventory, quarantine, and do not use the IOL from this impacted lot. 2) Provide this notice to all those who need to be aware within your organization or to any organization where the potentially affected devices have been transferred (as appropriate). Also, please transfer this notice to other organizations on which this action has an impact (as appropriate). Please maintain awareness of this notice and resulting action for an appropriate period to ensure effectiveness of the corrective action. 3) Complete and return the acknowledgement form via email to [email protected] For questions regarding this notice, please call firm at 1-800-338-2020, Option 9.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology